NEW YORK, Aug. 31, 2019 — Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Curaleaf Holdings, Inc. (OTC: CURLF) from November 21, 2018 through July 22, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Curaleaf investors under the federal securities laws.
If you wish to serve as lead plaintiff, you must move the Court no later than October 4, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to obtain a recovery is not dependent upon being a lead plaintiff. If you wish to join the https://zhanginvestorlaw.com/join-action-form/?slug=curaleaf-holdings-inc&id=1979 or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. or Spencer Lee toll-free at 800-991-3756 or email email@example.com, firstname.lastname@example.org for information on the class action.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration (“FDA”); and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class has not been certified. You may retain counsel of your choice. You may take no action at this time and be an absent class member. Your ability to obtain a recovery is not dependent upon being a lead plaintiff.
Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.
Zhang Investor Law P.C. 99 Wall Street, Suite 232 New York, New York 10005 email@example.com tel: (800) 991-3756